Intracellular L-PGDS–Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury
Circulation · 2025
DOI: 10.1161/circulationaha.124.070936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2025. Verfasst von Qingmei Hu und 19 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Q.H., J.L., F.L., L.J., P.X., W. Zheng, H.S.…. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Type 2, Myocardial Reperfusion Injury, Prostaglandin D2, Lipid Peroxidation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Myocardial ischemia/reperfusion (I/R) injury is a substantial challenge to the management of ischemic heart disease, the leading cause of mortality worldwide. Arachidonic acid (AA) is a prominent polyunsaturated fatty acid in the human body and plays an important role in various physiological and pathological conditions. AA metabolic enzymes determine AA levels; however, currently there is no comprehensive analysis of AA enzymes in cardiac I/R injury. METHODS: The profiling of AA metabolic enzymes was analyzed with the RNA sequencing transcriptome data from the mouse heart tissues with I/R injury. Cultured neonatal and adult rat ventricular myocytes, human embryonic stem cell–derived cardiomyocytes, and in vivo mouse I/R models were used to confirm the role of L-PGDS (lipocalin-type prostaglandin D2 synthase)/15d-PGJ2 in I/R injury. A biotin-tagged 15d-PGJ2 analog combined with liquid chromatography–tandem mass spectrometry was used to identify the downstream signaling of L-PGDS/15d-PGJ2. RESULTS: Based on the transcriptome data and experimental validations, L-PGDS, together with its downstream metabolite 15d-PGJ2, was downregulated in cardiac tissue with I/R injury. Functionally, L-PGDS overexpression mitigates myocardial I/R injury, whereas knockdown exacerbates the damage. Supplementation of 15d-PGJ2 alleviated I/R injury. Mechanistically, 15d-PGJ2 covalently bound to the CaMKII (Ca 2+ /calmodulin dependent protein kinase II) and induced lipoxidation of its cysteine 495 (CaMKII-δ9) to dampen the formation of CaMKII oligomers and alleviate its overactivation, consequently ameliorating cardiomyocyte death and cardiac injury. CONCLUSIONS: Our study uncovered L-PGDS/15d-PGJ2/CaMKII signaling as a new mechanism underlying I/R-induced cardiomyocyte death. This provides new mechanistic insights and therapeutic targets for myocardial I/R injury and subsequent heart failure. We also showed that lipoxidation is a new post-translational modification type for CaMKII, deepening our understanding of the regulation of its activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Q.H., J.L., F.L., L.J., P.X., W. Zheng, H.S., X.H., Z.C., R.-P.X.), Peking University, China.
- Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, State Key Laboratory of Vascular Homeostasis and Remodeling (J.Z.), Peking University, China.
- Beijing Key Laboratory of Cardiovascular Receptors Research, China (J.Z., Y.Z.).
- Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Haihe Laboratory of Cell Ecosystem, Beijing, China (J.Z.), Chin…
- Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Peking University Health Science Center, Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, State Key L…
- Institute of Energy (P.H.), Peking University, China.
ORCID-Profile: Qingmei Hu, Junxia Zhang, Xile Luo, Fan Li, Zeyuan Wang, Shuyang Zhang, Zishan Jiao, Yitong Liu, Wenneng Zhu, Xinli Hu, Zhixing Chen, Yan Zhang
Zitieren
APA
Hu, Q., Zhang, J., Luo, X., Hu, P., Li, J., Li, F., Wang, Z., Zhang, S., Jiao, Z., Liu, Y., Duanmu, J., Jin, L., Xie, P., Zhu, W., Zheng, W., Shang, H., Hu, X., Chen, Z., Xiao, R. P., & Zhang, Y. (2025). Intracellular L-PGDS–Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury. Circulation. https://doi.org/10.1161/circulationaha.124.070936
Vancouver
Hu Q, Zhang J, Luo X, Hu P, Li J, Li F, et al. Intracellular L-PGDS–Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury. Circulation. 2025. doi:10.1161/circulationaha.124.070936
BibTeX
@article{Hu2025,
author = {Hu, Qingmei and Zhang, Junxia and Luo, Xile and Hu, Peiyu and Li, Jiayi and Li, Fan and Wang, Zeyuan and Zhang, Shuyang and Jiao, Zishan and Liu, Yitong and Duanmu, Jiaxin and Jin, Li and Xie, Peng and Zhu, Wenneng and Zheng, Wen and Shang, Haibao and Hu, Xinli and Chen, Zhixing and Xiao, Rui-Ping and Zhang, Yan},
title = {Intracellular L-PGDS–Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury},
journal = {Circulation},
year = {2025},
doi = {10.1161/circulationaha.124.070936}
}
EUVIMED